Author

Z. Matsuda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Organism:human· 1 Organism:virus· 1

Frequent Co-Authors

J.-i. Inoue· 2 shared Y. Kawaguchi· 2 shared H. Wang· 1 shared J. Gohda· 1 shared J. Song· 1 shared K. Iwatsuki-Horimoto· 1 shared K. Semba· 1 shared M. Imai· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

J.-i. Inoue

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The anticoagulant nafamostat potently inhibits SARS-CoV-2 infection in vitro: an existing drug with multiple possible therapeutic effects

M. Yamamoto, M. Kiso, Y. Sakai-Tagawa, K. Iwatsuki-Horimoto, M. Imai, M. Takeda, N. Kinoshita, N. Ohmagari, J. Gohda, K. Semba, Z. Matsuda, Y. Kawaguchi, Y. Kawaoka, J.-i. Inoue

This study shows nafamostat inhibits SARS-CoV-2 infection in vitro by blocking TMPRSS2-mediated fusion, with potency exceeding its blood concentration, suggesting it as a potential COVID-19 treatment.

bioRxiv · Apr 22, 2020 · PreprintMicrobiology

Analysis of insertion mutants in distal α9 portion of C-terminal heptad repeat (CHR) of HIV-1 gp41 subunit

H. Wang, J. Song, Y. Kawaguchi, J.-i. Inoue, Z. Matsuda

The paper analyzes insertion mutants in the HIV-1 gp41 C-terminal heptad repeat, finding that alanine insertion (653+A) attenuates membrane fusion due to slower 6HB formation kinetics, not 6HB stability.

bioRxiv · Mar 30, 2020 · PreprintMicrobiology